Evidence map›Paper›PMID 41414960›Full record

ReviewHaematologica2026

NEAT1: a multifaceted long non-coding RNA in multiple myeloma.

Gabriele Benini, Sara Taranto, Margherita Sciumè, Fabio Rigali, Raffaella Marcheselli, Andrea Abate, Stefania Mitola, Sandra Sigala, Antonio Sacco, Aldo M Roccaro

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Haematologica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Gabriele BeniniClinical Trial Center, Translational Research and Phase I Unit ASST Spedali Civili di Brescia, BS.
Sara TarantoClinical Trial Center, Translational Research and Phase I Unit ASST Spedali Civili di Brescia, BS.
Margherita SciumèClinical Trial Center, Translational Research and Phase I Unit ASST Spedali Civili di Brescia, BS.
Fabio RigaliClinical Trial Center, Translational Research and Phase I Unit ASST Spedali Civili di Brescia, BS.
Raffaella MarcheselliClinical Trial Center, Translational Research and Phase I Unit ASST Spedali Civili di Brescia, BS.
Andrea AbateSection of Pharmacolgy, Department of Molecular and Translational Medicine, University of Brescia, BS.
Stefania MitolaDepartment of Molecular and Translational Medicine, University of Brescia, BS.
Sandra SigalaClinical Trial Center, Translational Research and Phase I Unit ASST Spedali Civili di Brescia, BS, Italy; Section of Pharmacolgy, Department of Molecular and Translational Medicine, University of Brescia, BS.
Antonio SaccoClinical Trial Center, Translational Research and Phase I Unit ASST Spedali Civili di Brescia, BS, Italy; Department of Molecular and Translational Medicine, University of Brescia, BS. antonio.sacco@asst-spedalicivili.it.
Aldo M RoccaroClinical Trial Center, Translational Research and Phase I Unit ASST Spedali Civili di Brescia, BS. aldomaria.roccaro@asst-spedalicivili.it.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Multiple myeloma (MM) is a plasma cell dyscrasia sustained by the clonal proliferation of plasma cells within the bone marrow. MM is the second most common hematologic neoplasm and, despite the continuous effort to overcome this disease, it remains uncurable. Throughout the recent years, novel therapeutic targets have been investigated, leading to the development of novel treatments for MM patients. In the last 10 years, interest in the long non-coding RNA NEAT1 has grown significantly within the field of cancer, including MM. In this review we offer a panoramic view of the role of NEAT1 in MM, with a focus on its possible role as both a biomarker and therapeutic target.

Indexed as

Multiple MyelomaRNA, Long NoncodingAnimalsBiomarkers, TumorGene Expression Regulation, NeoplasticHumansBiomarkers, TumorNEAT1 long non-coding RNA, humanRNA, Long Noncoding

Identifiers

PMID41414960
PMCPMC13231098

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.